Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 2
2005 2
2006 2
2007 2
2009 7
2010 8
2011 6
2012 10
2013 5
2014 6
2015 8
2016 9
2017 11
2018 17
2019 11
2020 8
2021 11
2022 15
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yingji wu[Author] (42 results)?
Deubiquitinases in hematological malignancies.
Lei H, Wang J, Hu J, Zhu Q, Wu Y. Lei H, et al. Among authors: wu y. Biomark Res. 2021 Aug 28;9(1):66. doi: 10.1186/s40364-021-00320-w. Biomark Res. 2021. PMID: 34454635 Free PMC article. Review.
Nanoparticle-Based Combination Therapy for Ovarian Cancer.
Wu Y, Yang Y, Lv X, Gao M, Gong X, Yao Q, Liu Y. Wu Y, et al. Int J Nanomedicine. 2023 Apr 12;18:1965-1987. doi: 10.2147/IJN.S394383. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37077941 Free PMC article. Review.
Targeting peroxiredoxins against leukemia.
Liu CX, Zhou HC, Yin QQ, Wu YL, Chen GQ. Liu CX, et al. Exp Cell Res. 2013 Jan 15;319(2):170-6. doi: 10.1016/j.yexcr.2012.06.013. Epub 2012 Jun 20. Exp Cell Res. 2013. PMID: 22728267 Review.
Targeting deubiquitinating enzymes in cancer stem cells.
Lei H, Shan H, Wu Y. Lei H, et al. Among authors: wu y. Cancer Cell Int. 2017 Nov 3;17:101. doi: 10.1186/s12935-017-0472-0. eCollection 2017. Cancer Cell Int. 2017. PMID: 29142505 Free PMC article. Review.
Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance.
Yin LM, Xu YD, Peng LL, Duan TT, Liu JY, Xu Z, Wang WQ, Guan N, Han XJ, Li HY, Pang Y, Wang Y, Chen Z, Zhu W, Deng L, Wu YL, Ge GB, Huang S, Ulloa L, Yang YQ. Yin LM, et al. Sci Transl Med. 2018 Feb 7;10(427):eaam8604. doi: 10.1126/scitranslmed.aam8604. Sci Transl Med. 2018. PMID: 29437149 Free PMC article.
137 results